Choroidal Response to the Modified Defocus Incorporated Multiple Segments Spectacle Lenses

ConditionMyopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-13
SponsorThe Hong Kong Polytechnic University

About this trial

The goal of this study is to investigate the short-term changes in choroidal thickness and efficacy of the study spectacle lenses in children. Participants will be prescribed with a pair of study spectacle lenses for daily use and visit the clinic once every week for the first month for checkup and tests. After the first month of follow-up, participants will visit at 1 month, 6- and 12-month for checkup. Choroidal thickness, axial length and refractive errors will be monitored.

Eligibility criteria

Qualifiers

Hong Kong Chinese

Age at enrolment: 6 - 13 years

Myopia in spherical power: -1.00D to -5.00D in both eyes

Astigmatism: equal or less than 2.00D

Disqualifiers

Previous or current treatment for myopia control (e.g., red-light therapy, atropine, orthokeratology, specialized spectacle lenses and contact lenses and oral supplements for myopic control)

Existing or past eye diseases or surgeries (e.g., strabismus surgery, amblyopia, oculomotor nerve palsies, corneal disease, intraocular disease, etc.) that may have an impact on vision or visual development

Long-term medication (intake at least 3 days/week) or medication/supplements that affect eye health

Systemic diseases that may have an impact on vision or visual development (e.g., endocrine, cardiac and respiratory diseases, diabetes, Down syndrome, etc.)

Trial design

Treatments tested in this trial

  • Modified Defocus Incorporated Multiple Segments lens (D1)
  • Modified Defocus Incorporated Multiple Segments lens (D2)

Treatment groups

108 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

The Hong Kong Polytechnic University

Lead sponsor

HOYA Lens Thailand LTD.

Collaborator